Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-16

Clinical Trial Update: Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Albiglutide was studied in a Phase 2 glucose clamp study in adults with type 2 diabetes. The study has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tanzeum (Albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-05-16